These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22129752)

  • 1. Overexpression of CLN1, CLN2, or ERG13 increases resistance to adriamycin in Saccharomyces cerevisiae.
    Takahashi T; Nakashima S; Masuda T; Yoneda S; Hwang GW; Naganuma A
    J Toxicol Sci; 2011; 36(6):855-7. PubMed ID: 22129752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Ssl2p confers resistance to adriamycin and actinomycin D in Saccharomyces cerevisiae.
    Furuchi T; Nitta K; Takahashi T; Naganuma A
    Biochem Biophys Res Commun; 2004 Feb; 314(3):844-8. PubMed ID: 14741713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between the MEC1-dependent DNA synthesis checkpoint and G1 cyclin function in Saccharomyces cerevisiae.
    Vallen EA; Cross FR
    Genetics; 1999 Feb; 151(2):459-71. PubMed ID: 9927443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel role for Bsd2 in the resistance of yeast to adriamycin.
    Takahashi T; Furuchi T; Naganuma A
    J Cell Physiol; 2005 Jan; 202(1):100-4. PubMed ID: 15389553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G1 cyclins CLN1 and CLN2 repress the mating factor response pathway at Start in the yeast cell cycle.
    Oehlen LJ; Cross FR
    Genes Dev; 1994 May; 8(9):1058-70. PubMed ID: 7926787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of CLN1 and CLN2 in the Saccharomyces cerevisiae whi2 mutant.
    Radcliffe P; Trevethick J; Tyers M; Sudbery P
    Yeast; 1997 Jun; 13(8):707-15. PubMed ID: 9219335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching transcription on and off during the yeast cell cycle: Cln/Cdc28 kinases activate bound transcription factor SBF (Swi4/Swi6) at start, whereas Clb/Cdc28 kinases displace it from the promoter in G2.
    Koch C; Schleiffer A; Ammerer G; Nasmyth K
    Genes Dev; 1996 Jan; 10(2):129-41. PubMed ID: 8566747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of the functional distinction between Cln1 and Cln2 cyclins.
    Quilis I; Igual JC
    Cell Cycle; 2012 Aug; 11(16):3117-31. PubMed ID: 22889732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A screen for genes involved in adriamycin resistance in Saccharomyces cerevisiae].
    Takahashi T
    Yakugaku Zasshi; 2013; 133(3):393-6. PubMed ID: 23449420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocytic Ark/Prk kinases play a critical role in adriamycin resistance in both yeast and mammalian cells.
    Takahashi T; Furuchi T; Naganuma A
    Cancer Res; 2006 Dec; 66(24):11932-7. PubMed ID: 17178891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POG1, a novel yeast gene, promotes recovery from pheromone arrest via the G1 cyclin CLN2.
    Leza MA; Elion EA
    Genetics; 1999 Feb; 151(2):531-43. PubMed ID: 9927449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connections between the Ras-cyclic AMP pathway and G1 cyclin expression in the budding yeast Saccharomyces cerevisiae.
    Hubler L; Bradshaw-Rouse J; Heideman W
    Mol Cell Biol; 1993 Oct; 13(10):6274-82. PubMed ID: 8413227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation of CLN1, CLN2, and a putative new G1 cyclin (HCS26) by SWI4, a positive regulator of G1-specific transcription.
    Ogas J; Andrews BJ; Herskowitz I
    Cell; 1991 Sep; 66(5):1015-26. PubMed ID: 1832336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of Cln3 in filamentous growth and invasive growth of Saccharomyces cerevisiae].
    Ni J; Liu XY; Chen JY
    Shi Yan Sheng Wu Xue Bao; 2004 Apr; 37(2):145-50. PubMed ID: 15259988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transcriptional autoregulatory loop for KIN28-CCL1 and SRB10-SRB11, each encoding RNA polymerase II CTD kinase-cyclin pair, stimulates the meiotic development of S. cerevisiae.
    Ohkuni K; Yamashita I
    Yeast; 2000 Jun; 16(9):829-46. PubMed ID: 10861906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosage suppressors of the dominant G1 cyclin mutant CLN3-2: identification of a yeast gene encoding a putative RNA/ssDNA binding protein.
    Sugimoto K; Matsumoto K; Kornberg RD; Reed SI; Wittenberg C
    Mol Gen Genet; 1995 Oct; 248(6):712-8. PubMed ID: 7476874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulating the mevalonate pathway and repressing sterol synthesis in Saccharomyces cerevisiae enhances the production of triterpenes.
    Bröker JN; Müller B; van Deenen N; Prüfer D; Schulze Gronover C
    Appl Microbiol Biotechnol; 2018 Aug; 102(16):6923-6934. PubMed ID: 29948122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIT4 protein phosphatase is required for the normal accumulation of SWI4, CLN1, CLN2, and HCS26 RNAs during late G1.
    Fernandez-Sarabia MJ; Sutton A; Zhong T; Arndt KT
    Genes Dev; 1992 Dec; 6(12A):2417-28. PubMed ID: 1334024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small ubiquitin-related modifier pathway is a major determinant of doxorubicin cytotoxicity in Saccharomyces cerevisiae.
    Huang RY; Kowalski D; Minderman H; Gandhi N; Johnson ES
    Cancer Res; 2007 Jan; 67(2):765-72. PubMed ID: 17234788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle control by a complex of the cyclin HCS26 (PCL1) and the kinase PHO85.
    Espinoza FH; Ogas J; Herskowitz I; Morgan DO
    Science; 1994 Nov; 266(5189):1388-91. PubMed ID: 7973730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.